(Q45750926)

15 December 2017

title

Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles (English)

1 reference

15 December 2017

author name string

Jiang B

1

1 reference

15 December 2017

Estes MK

2

1 reference

15 December 2017

Barone C

3

1 reference

15 December 2017

Barniak V

4

1 reference

15 December 2017

O'Neal CM

5

1 reference

15 December 2017

Ottaiano A

6

1 reference

15 December 2017

Madore HP

7

1 reference

15 December 2017

Conner ME

8

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

17

1 reference

15 December 2017

issue

7-8

1 reference

15 December 2017

page(s)

1005-1013

1 reference

15 December 2017

Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Summary of the Fifth Rotavirus Vaccine Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Virus-like particles as a rotavirus subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Control of Influenza and Poliomyelitis with Killed Virus Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Rotavirus vaccine administered parenterally induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900317-X

7 January 2021

10.1016/S0264-410X(98)00317-X

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017